Factors modifying transcriptional regulation of signaling genes have putative role in tumor development and progression in humans

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 805-812

  Qidwai, M Tabish ^a   Jamal, Farrukh ^b   Singh, Dharmendrapal ^a   Sharma, Ratnesh K ^c  

^a R B S COLLEGE   (India)

^b DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

^c UNIVERSITY OF ALLAHABAD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; INTERLEUKIN 6; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; REGULATOR PROTEIN; STAT3 PROTEIN;

ARTICLE; CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; DNA MODIFICATION; DNA POLYMORPHISM; DNA SEQUENCE; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; PROMOTER REGION; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

DISEASE PROGRESSION; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MODELS, THEORETICAL; NEOPLASMS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84869081566     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.08.033     Document Type: Article

References (38)

1. Kuriki C., Tanaka T., Fukui Y., Sato O., Motojima K. Structural and functional analysis of a new upstream promoter of the human FAT/CD36 gene. Biol Pharm Bull 2002, 25:1476-1478.
2. Andersen M.C., Engström P.G., et al. In Silico detection of sequence variations modifying transcriptional regulation. PLoS Comput Biol 2008, 4(1):e5. doi:10.1371.
3. Ali-Osman F., et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione s-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997, 272:10004-10012.
4. Zhou W., Chen Z., Hu W., Shen M., Zhang X., Li C., et al. Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer. PLoS One 2011, 6(5):e20378.
5. Malek J.A., Mery E., Mahmoud Y.A., Al-Azwani E.K., Roger L., Huang R., et al. Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One 2011, 6(12):e28561.
6. Lu T.P., Lai L.C., Tsai M.H., Chen P.C., Hsu C.P., Lee J.M., et al. Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PLoS One 2011, 6(9):e24829.
7. Herman J.G., Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054.
8. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
9. Qureshi K., Lee S., Lou W., Trump D., Gao A. Targeting STAT3 signaling in human prostate cancer cells using tyrosine kinase inhibitors. J Clin Oncol 2004, 22(14S):3138.
10. Hobisch A., Eder I.E., Putz T., Horninger W., Bartsch G., Klocker H., et al. Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 1998, 58:4640-4645.
11. Culig Z., Hobisch A., Cronauer M.V., Radmayr C., Trapman J., Hittmair A., et al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994, 54:5474-5478.
12. Drachenberg D.E., Elgamal A.A., Rowbotham R., Peterson M., Murphy G.P. Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate 1999, 41:127-133.
13. Qiu Y., Ravi L., Kung H.J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature (London) 1998, 393:83-85.
14. Zhang Z., Jones S., Hagood J.S., Fuentes N.L., Fuller G.M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 1997, 272:30607-30610.
15. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. STAT3 as an oncogene. Cell 1999, 98:295-303.
16. Phillips T. The role of methylation in gene expression. Nat Educ 2008, 1:1.
17. Lonergan P.E., Tindall D.J. Androgen receptor signaling in prostate cancer development and progression. J Carcinog 2011, 10:20.
18. Lou W., Ni Z., Dyer K., Tweardy D.J., Gao A.C. Interleukin-6 induces prostate cancer cell growth accompanied by activation of STAT3 signaling pathway. Prostate 2000, 42:239-242.
19. Catlett-Faclone R., Landowski T.H., Oshiro M.M., Turkson J., Levitzki A., Savino R., et al. Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999, 10:105-115.
20. Zhang Y., Rohde C., Tierling S., Jurkowski T.P., Bock C., et al. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet 2009, 5(3):e1000438. 10.1371/journal.pgen.1000438.
21. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31:89-97.
22. Kim T.H., Barrera L.O., Zheng M., Qu C., Singer M.A., et al. A high resolution map of active promoters in the human genome. Nature 2005, 436:876-880.
23. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007, 39:457-466.
24. Meissner A., Mikkelsen T.S., Gu H., Wernig M., Hanna J., et al. Genome scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454:766-770.
25. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006, 38:1378-1385.
26. Heel D.A.V., Udalova I.A., Silva A.P.D., et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kB transcription factors. Hum Mol Genet 2002, 11:1281-1289.
27. Sinha S., Mishra S.K., Sharma S., et al. Polymorphisms of TNF-enhancer and gene for Fc gamma RIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 2008, 7:13.
28. Lee G.H., Choi Y.M., Kim S.H., Hong M.A., Oh S.T., Lim Y.T., et al. Association of tumor necrosis factor-α gene polymorphisms with advanced stage endometriosis. Hum Reprod 2008, 23:977-981.
29. Sinha S., Jha G.N., Anand P., Qidwai T., et al. CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity. Hum Immunol 2009, 70:244-250.
30. Sinha S., Qidwai T., Kanchan K., et al. Distinct cytokine profiles define immune response to falciparum malaria in region of high and low transmission. Eur Cytokine Netw 2010, 21(4):232-240.
31. Jha P., Sinha S., Kanchan K., Qidwai T., et al. Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria. Infect Genet Evol 2012, 12(1):142-148.
32. Beer T.M., Evans A.J., Hough K.M., Lowe B.A., McWilliams J.E., Henner W.D. Polymorphisms of GSTP1 and related genes and prostate cancer risk. Prostate Cancer Prostatic Dis 2002, 5:22-27.
33. Valsesia A., Rimoldi D., Martinet D., et al. Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS One 2011, 6(4):e18369.
34. Gonzalez Gay M.A., Llorca J., Palomino-Morales R., Gomez-Acebo I., Gonzalez-Juanatey C., Martin J. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. Clin Exp Rheumatol 2009, 27(1):116-119.
35. Stern D.L., Orgogozo V. The loci of evolution: how predictable is genetic evolution?. Evolution 2008, 62:2155-2177.
36. Averof M., Patel N.H. Crustacean appendage evolution associated with changes in Hox gene expression. Nature 1997, 388:682-686.
37. Wittkopp P.J. Variable transcription factor binding: a mechanism of evolutionary change. PLoS Biol 2010, 8(3):e1000342.
38. Bradley R.K., Li X.Y., Trapnell C., et al. Binding site turnover produces pervasive quantitative changes in transcription factor binding between closely related Drosophila species. PLoS Biol 2010, 8:e1000343.